Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Background: Estimates of the humoral immune response to incident human papillomavirus (HPV) infections are limited. Methods: In this post hoc analysis of 3875 women aged 16–23 years from a 4-valent HPV vaccine trial (NCT00092482), HPV seroprevalence on day 1 was measured with a 9-valent HPV (HPV 6/1...

Full description

Bibliographic Details
Main Authors: Darron R. Brown, Xavier Castellsagué, Daron Ferris, Suzanne M. Garland, Warner Huh, Marc Steben, Cosette M. Wheeler, Alfred Saah, Alain Luxembourg, Se Li, Christine Velicer
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Tumour Virus Research
Subjects:
Human papillomavirus
HPV serology
HPV vaccines
HPV infection
Seroconversion
Seroprevalence
Online Access:http://www.sciencedirect.com/science/article/pii/S2666679022000027

Internet

http://www.sciencedirect.com/science/article/pii/S2666679022000027

Similar Items